118 related articles for article (PubMed ID: 38852884)
1. Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production.
Dufresne K; DiMaggio DA; Maduta CS; Brinsmade SR; McCormick JK
J Biol Chem; 2024 Jun; ():107455. PubMed ID: 38852884
[TBL] [Abstract][Full Text] [Related]
2. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
3. Glucose Mediates Niche-Specific Repression of Staphylococcus aureus Toxic Shock Syndrome Toxin-1 through the Activity of CcpA in the Vaginal Environment.
Dufresne K; Podskalniy VA; Herfst CA; Lovell GFM; Lee IS; DeJong EN; McCormick JK; Tuffs SW
J Bacteriol; 2022 Oct; 204(10):e0026922. PubMed ID: 36106854
[TBL] [Abstract][Full Text] [Related]
4. The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.
Baroja ML; Herfst CA; Kasper KJ; Xu SX; Gillett DA; Li J; Reid G; McCormick JK
J Bacteriol; 2016 Oct; 198(19):2732-42. PubMed ID: 27457715
[TBL] [Abstract][Full Text] [Related]
5. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
Schlievert PM
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Onset of Staphylococcal Non-menstrual Toxic Shock Syndrome With Inducibility of Toxic Shock Syndrome Toxin-1 Production.
Taki Y; Watanabe S; Sato'o Y; Tan XE; Ono HK; Kiga K; Aiba Y; Sasahara T; Azam AH; Thitiananpakorn K; Veeranarayanan S; Li FY; Zhang Y; Kawaguchi T; Hossain S; Maniruzzaman ; Hu DL; Cui L
Front Microbiol; 2022; 13():765317. PubMed ID: 35369432
[TBL] [Abstract][Full Text] [Related]
7. Vaginal Tampon Colonization by Staphylococcus aureus in Healthy Women.
Chiaruzzi M; Barbry A; Muggeo A; Tristan A; Jacquemond I; Badiou C; Cluzeau L; Bourdeau S; Durand T; Engelmann A; Bosquet D; Bes M; Prigent-Combaret C; Thioulouse J; Muller D; Lina G
Appl Environ Microbiol; 2020 Sep; 86(18):. PubMed ID: 32680868
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Toxic Shock Syndrome-Associated
Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
[TBL] [Abstract][Full Text] [Related]
9. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production
Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918
[TBL] [Abstract][Full Text] [Related]
10. Targeted Proteomics Analysis of Staphylococcal Superantigenic Toxins in Menstrual Fluid from Women with Menstrual Toxic Shock Syndrome (mTSS).
Courçon M; Badiou C; Louwagie M; Etievant S; Jaquinod M; Lina G; Brun V
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548783
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
[TBL] [Abstract][Full Text] [Related]
12. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
[TBL] [Abstract][Full Text] [Related]
13. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.
Kansal R; Davis C; Hansmann M; Seymour J; Parsonnet J; Modern P; Gilbert S; Kotb M
J Clin Immunol; 2007 May; 27(3):327-38. PubMed ID: 17340193
[TBL] [Abstract][Full Text] [Related]
15. VfrB Is a Key Activator of the Staphylococcus aureus SaeRS Two-Component System.
Krute CN; Rice KC; Bose JL
J Bacteriol; 2017 Mar; 199(5):. PubMed ID: 28031278
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.
Parsonnet J; Goering RV; Hansmann MA; Jones MB; Ohtagaki K; Davis CC; Totsuka K
J Clin Microbiol; 2008 Aug; 46(8):2731-8. PubMed ID: 18550735
[TBL] [Abstract][Full Text] [Related]
18. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
19. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
20. Toxin exposure and HLA alleles determine serum antibody binding to toxic shock syndrome toxin 1 (TSST-1) of
Weiss S; Holtfreter S; Meyer TC; Schmiedeke F; Cammann C; Dörr M; Felix SB; Grabe HJ; Homuth G; Kohler C; Mahncke C; Michalik S; Nauck M; Friedrich N; Samietz S; Völzke H; Völker U; Bröker BM
Front Immunol; 2023; 14():1229562. PubMed ID: 37731490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
